Combination of ERA and SGLT2 inhibitor reduced albuminuria in patients with chronic kidney disease: ZENITH-CKD trial Medha Baranwal23 Nov 2023 9:30 AM ISTNetherlands: A combination of zibotentan and dapagliflozin reduced albuminuria with an acceptable safety and tolerability profile, according to phase...
Evergreen Talk Series: Clinical Benefits of Linagliptin and Dapagliflozin Combination in Type 2 Diabetes Management MD Brand Connect10 Nov 2023 11:54 AM IST Advertisement Presenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a...
Continuation of dapagliflozin beneficial among HF patients with deteriorating kidney function Dr.Niharika Harsha B8 Nov 2023 7:00 PM ISTIn a recent study, researchers have explored the safety and effectiveness of continuing treatment with sodium-glucose cotransporter-2 (SGLT2)...
Zibotentan plus dapagliflozin demonstrated significant albuminuria reduction in patients with chronic kidney disease, proteinuria: AstraZeneca Ruchika Sharma5 Nov 2023 1:00 PM ISTCambridge: AstraZeneca has announced that the combination of zibotentan with dapagliflozin has shown statistically significant and clinically...
Exemed Gets CDSCO Panel Nod To study dapagliflozin, Sacubitril, Valsartan as Sodium salt tablet Dr. Divya Colin29 Oct 2023 1:21 PM ISTNew Delhi: Exemed Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Abbott Gets CDSCO Panel Nod To Study Antidiabetic FDC Dapagliflozin plus Metformin Dr. Divya Colin21 Oct 2023 7:00 PM ISTNew Delhi: The drug major Abbott Healthcare has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Dapagliflozin or saxagliptin, which is better for children with type 2 diabetes? Medha Baranwal21 Oct 2023 11:15 AM ISTUSA: A phase III T2NOW trial comparing dapagliflozin or saxagliptin in pediatric type 2 diabetes revealed that Dapagliflozin (Farxiga) lowered HbA1c...
Dapagliflozin safely improves outcomes in people with apparent treatment-resistant hypertension: DELIVER Trial Medha Baranwal16 Oct 2023 11:30 AM ISTUSA: In a post hoc analysis of the DELIVER trial dapagliflozin was shown to be well-tolerated and consistently improved clinical outcomes, including...
Dapagliflozin may improve erectile dysfunction among diabetes patients Medha Baranwal12 Oct 2023 10:45 AM ISTItaly: A recent study published in Diabetic Medicine has shown the positive effect of dapagliflozin on erectile function in patients with type 2...
AstraZeneca Forxiga meets primary endpoint for type 2 diabetes Ruchika Sharma8 Oct 2023 10:00 AM ISTCambridge: AstraZeneca has announced positive results from the T2NOW Phase III trial, one of the largest paediatric type 2 diabetes studies performed...
Linagliptin applicable across wide group of T2DM patients- Latest Indian Position Paper Dr. Nandita Mohan30 Sept 2023 11:30 AM IST As per the latest Indian position statement released in the Journal of the Association of Physicians of India, August 2023 issue, Linagliptin...
USV Launches Liralin Range for Diverse Group of Type 2 Diabetes Patients MD Brand Connect4 Sept 2023 1:55 PM ISTUSV Pvt. Ltd, a leading drug manufacturer in the diabetes & cardiology segment, has announced the launch of the Liralin Range for the treatment...
